AU2001295665A1 - Use of a composition with antioxidant activity for conditioning stem cells - Google Patents

Use of a composition with antioxidant activity for conditioning stem cells

Info

Publication number
AU2001295665A1
AU2001295665A1 AU2001295665A AU9566501A AU2001295665A1 AU 2001295665 A1 AU2001295665 A1 AU 2001295665A1 AU 2001295665 A AU2001295665 A AU 2001295665A AU 9566501 A AU9566501 A AU 9566501A AU 2001295665 A1 AU2001295665 A1 AU 2001295665A1
Authority
AU
Australia
Prior art keywords
stem cells
composition
antioxidant activity
conditioning
conditioning stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001295665A
Inventor
Odile Cohen-Haguenauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IGR ET D
Original Assignee
IGR ET D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IGR ET D filed Critical IGR ET D
Publication of AU2001295665A1 publication Critical patent/AU2001295665A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/14—Erythropoietin [EPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/145—Thrombopoietin [TPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention concerns the use of a composition with antioxidant activity for conditioning in vitro stem cells and in particular hematopoietic cells, for therapeutic use thereof. The invention concerns in particular the use of N-acetylcysteine, and the hematopoietic stem cells conditioned with N-acetylcysteine.
AU2001295665A 2000-10-06 2001-10-05 Use of a composition with antioxidant activity for conditioning stem cells Abandoned AU2001295665A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0012845 2000-10-06
FR00/12845 2000-10-06
FR0012845A FR2815042B1 (en) 2000-10-06 2000-10-06 USE OF A COMPOSITION WITH ANTIOXIDANT ACTIVITY FOR THE PACKAGING OF STEM CELLS
PCT/FR2001/003087 WO2002029011A2 (en) 2000-10-06 2001-10-05 Use of a composition with antioxidant activity for conditioning stem cells

Publications (1)

Publication Number Publication Date
AU2001295665A1 true AU2001295665A1 (en) 2002-04-15

Family

ID=8855112

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001295665A Abandoned AU2001295665A1 (en) 2000-10-06 2001-10-05 Use of a composition with antioxidant activity for conditioning stem cells

Country Status (6)

Country Link
EP (1) EP1363995B1 (en)
AT (1) ATE455846T1 (en)
AU (1) AU2001295665A1 (en)
DE (1) DE60141169D1 (en)
FR (1) FR2815042B1 (en)
WO (1) WO2002029011A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006506970A (en) 2002-07-12 2006-03-02 ユニバーシティ オブ ワシントン Methods and systems for extended in vitro culture of neurons
JPWO2005121320A1 (en) * 2004-06-10 2008-04-10 協和醗酵工業株式会社 Stem cell self-renewal promoter
KR100679642B1 (en) 2005-11-16 2007-02-06 주식회사 알앤엘바이오 Multipotent stem cell derived from human adipose tissue and cellular therapeutic agents comprising the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2114817B1 (en) * 1996-05-16 1999-02-16 Zambon S A PHARMACOLOGICAL ASSOCIATION BETWEEN N-ACETILCISTEINA AND LEVULOSA FOR THE PREVENTION OF CELL DEATH AND ASSOCIATED DISEASES.
WO1999056759A1 (en) * 1998-05-07 1999-11-11 University Of South Florida Bone marrow cells as a source of neurons for brain and spinal cord repair
JP3291698B2 (en) * 1998-07-24 2002-06-10 スティーブン・カーティン Variable eyeglass lens

Also Published As

Publication number Publication date
DE60141169D1 (en) 2010-03-11
WO2002029011A2 (en) 2002-04-11
EP1363995B1 (en) 2010-01-20
EP1363995A2 (en) 2003-11-26
ATE455846T1 (en) 2010-02-15
FR2815042B1 (en) 2005-01-07
FR2815042A1 (en) 2002-04-12
WO2002029011A3 (en) 2002-07-18

Similar Documents

Publication Publication Date Title
CA96336S (en) Cooler
AU2002227300A1 (en) Reducing cellular damage in the human body
AU2001258186A1 (en) Lamp, in particular, lounge, table or pocket lamp
EP2465924A3 (en) Isolated cells and populations comprising same for the treament of cns diseases
AU2001268535A1 (en) Devices and methods for repair of valves in the human body
CA101100S (en) Pillow
CA114064S (en) Catamenial absorbent pad
CA98120S (en) Arch support insole
IL150984A0 (en) Modified cytokines for use in cancer therapy
MY146794A (en) Use of an alpha-2-delta ligand for the treatment of luts
AU1074902A (en) Kahalalide f
AU2003233222A1 (en) Aqueous polyurethane preparations
AU1705599A (en) Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral blood
AU2001295665A1 (en) Use of a composition with antioxidant activity for conditioning stem cells
AU6028001A (en) Endoprosthesis part for use in joint replacement, use of the same and productionmethod therefor
AU144678S (en) Bottle
NZ509051A (en) Chemotaxis-inhibiting protein of staphylococcus (CHIPS) and its use
AU6488000A (en) Air distribution inside the refrigerator body
GB9923858D0 (en) Antimicrobial compositions
CA122265S (en) Pouch for pencils or the like
CA119712S (en) Catamenial absorbent pad
AU5780999A (en) Genes that regulate hematopoietic blood forming stem cells and uses thereof
AU2002302551A1 (en) Flavone synthase i enzymes and the use thereof
CA96704S (en) Bottle
WO1999024052A3 (en) Use of protein h as cytostatic agent